Qsemble Capital Management, LP Repligen Corp Transaction History
Qsemble Capital Management, LP
- $527 Billion
- Q2 2024
A detailed history of Qsemble Capital Management, LP transactions in Repligen Corp stock. As of the latest transaction made, Qsemble Capital Management, LP holds 1,853 shares of RGEN stock, worth $259,290. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,853Holding current value
$259,290% of portfolio
0.04%Shares
3 transactions
Others Institutions Holding RGEN
# of Institutions
495Shares Held
53.9MCall Options Held
420KPut Options Held
85.3K-
Black Rock Inc. New York, NY7.57MShares$1.06 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.07MShares$709 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.61MShares$645 Million0.07% of portfolio
-
State Street Corp Boston, MA1.74MShares$243 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA1.42MShares$199 Million0.55% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.76B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....